期刊文献+

细胞因子对初诊急性早幼粒细胞白血病患者早期死亡的影响

Effects of Cytokines on Early Death in Patients with Newly Diagnosed Acute Promyelocytic Leukemia
下载PDF
导出
摘要 目的:探索细胞因子对初诊急性早幼粒细胞白血病(APL)患者早期死亡及凝血功能障碍的影响。方法:69例初诊APL患者入院时完善常规检查,采集空腹静脉血4 ml,离心后取上清液,通过相应试剂盒检测细胞因子浓度及铁蛋白、乳酸脱氢酶(LDH)的浓度。结果:本研究证实急性脑血管意外是APL患者早期死亡的主要原因;LDH升高、血小板数(PLT)下降及凝血酶原时间(PT)延长是早期死亡的高危因素(P<0.05);IL-5、IL-6、IL-10、IL-12p70、IL-17A升高与初诊APL患者早期死亡密切相关,IL-5、IL-17A升高引起PT延长诱发凝血障碍(P<0.05);初诊时铁蛋白、LDH对IL-5、IL-10、IL-17A表达有正向影响,尤其是铁蛋白与IL-5(r=0.867)、IL-17A(r=0.841)呈高度正相关;5种高危细胞因子之间也有一定联系,其中IL-5与IL-17A(r=0.827)、IL-6与IL-10(r=0.823)呈高度正相关。结论:初诊APL患者细胞因子水平升高导致早期出血及死亡风险增加。铁蛋白及LDH正向影响细胞因子表达,从而影响APL患者预后,细胞因子之间也相互影响。 Objective:To explore the effect of cytokine levels on early death and coagulation function of patients with newly diagnosed acute promyelocytic leukemia(APL).Methods:Routine examination was performed on 69 newly diagnosed APL patients at admission.Meanwhile,4 ml fasting venous blood was extracted from the patients.And then the supernatant was taken after centrifugation.The concentrations of cytokines,lactate dehydrogenase(LDH)and ferritin were detected by using the corresponding kits.Results:It was confirmed that cerebral hemorrhage was a major cause of early death in APL patients.Elevated LDH,decreased platelets(PLT)count and prolonged prothrombin time(PT)were high risk factors for early death(P<0.05).The increases of IL-5,IL-6,IL-10,IL-12p70 and IL-17A were closely related to the early death of newly diagnosed APL patients,and the increases of IL-5 and IL-17A also induced coagulation disorder in APL patients by prolonging PT(P<0.05).In newly diagnosed APL patients,ferritin and LDH showed a positive effect on the expression of IL-5,IL-10 and IL-17A,especially ferritin had a highly positive correlation with IL-5(r=0.867)and IL-17A(r=0.841).Moreover,there was a certain correlation between these five high-risk cytokines,among which IL-5 and IL-17A(r=0.827),IL-6 and IL-10(r=0.823)were highly positively correlated.Conclusion:Elevated cytokine levels in newly diagnosed APL patients increase the risk of early bleeding and death.In addition to the interaction between cytokines themselves,ferritin and LDH positively affect the expression of cytokines,thus affecting the prognosis of APL patients.
作者 赵世香 葛圆圆 李增政 何海萍 沈承敏 史克倩 杨同华 杜云云 ZHAO Shi-Xiang;GE Yuan-Yuan;LI Zeng-Zheng;HE Hai-Ping;SHEN Cheng-Min;SHI Ke-Qian;YANG Tong-Hua;DU Yun-Yun(Department of Hematology,The First People's Hospital of Yunnan Province,The Affiliated Hospital of Kunming University of Science and Technology,Kunming 650100,Yunnan Province,China;Faculty of Life Science and Biotechnology,Kunming University of Science and Technology,Kunming 650500,Yunnan Province,China;Department of Cardiology,The 920th Hospital of Joint Logistics Support Force,Kunming 650032,Yunnan Province,China)
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2023年第5期1315-1321,共7页 Journal of Experimental Hematology
基金 云南省临床医学中心开放项目(2019LCZXKF-XY03,2021LCZXKF-XY09,2022LCZXKF-XY08) 云南省科技厅-昆明医科大学联合专项(202201AY070001-227) 国家自然科学基金(82260029) 云南省科技厅科技计划项目(202201AY070001-230)。
关键词 细胞因子 急性早幼粒细胞白血病 凝血障碍 铁蛋白 LDH cytokines acute promyelocytic leukemia coagulopathy ferritin lactate dehydrogenase
  • 相关文献

参考文献3

二级参考文献16

  • 1Hair GA, Padula S, Zeff R, et al. Tissue factor expression in human leukemic cells. Leukemia Res, 1996, 20(1):1-11.
  • 2McWilliam N, Robbie L, Booth N, et al. Plasminogen activator in acute myeloid leukemic marrows: u-PA in contrast to t-PA in normal marrow. Br Haemat, 1998,101(4):626-631.
  • 3Scherrer A, Wohlwend A, Kruithof EK, et al. Plasminogen activation in human acute leukemia. Br Haemat,1999,105(4):920-927.
  • 4Aref S, E1-Sherbiny M, Mabed M, et al. Urokinase plasminogen activator receptor and soluble matrix metalloproteinase-9 in acute myeloid leukemia patients:a possible relation to disease invasion.Hematology, 2003,8 (6) : 385-391.
  • 5Choi KS, Fitzpatrick SL, Filipenko NR, et al. Regulation of plasmin dependent fibrin clot lysis by annexin Ⅱ heterotetramer. J Biol Chem,2001, 276(27) :25212-25221.
  • 6Menell JS, Cesarman GM, Jacovina AT, et al. AnnexinII and bleeding in acute promyelocytic leukemia. N Engl J Med, 1999,340(13):994-1004.
  • 7Zhang X, Zhou H, Wang J, et al. Arsenic trioxide, retinoic acid and Ara-c regulation the expression of annexin II on the surface of APL cells, a novel co-receptor for plasminogen/tissue plasminogen activator. Thromb Res,2002,106(1):63-70.
  • 8Olwill SA, McGlynn H, Gilmore WS, et al. AnnexinII cell surface and mRNA expression in human acute myeloid leukemia cell lines. Thromb Res, 2005,115(1-2):109-114.
  • 9Hryszko T, Malyszko J, Brzosko S, et al. TAFI-thrombin activated fibrinolysis inhibitor. Przeglad Lekarski, 2001, 58 (3):136-138.
  • 10Meijers JC, Oudijk EJ, Mosnier LO, et al. Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor ) in acute promyelocytic leukaemia. Br Haemat, 2000,108(3):518-523.

共引文献224

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部